AURO-RAMIPRIL TABLETS 2.5 ramipril 2.5mg tablet blister pack

Krajina: Austrália

Jazyk: angličtina

Zdroj: Department of Health (Therapeutic Goods Administration)

Kúpte ho teraz

Aktívna zložka:

ramipril, Quantity: 2.5 mg

Dostupné z:

Arrotex Pharmaceuticals Pty Ltd

INN (Medzinárodný Name):

Ramipril

Forma lieku:

Tablet, uncoated

Zloženie:

Excipient Ingredients: pregelatinised maize starch; sodium bicarbonate; iron oxide yellow; sodium stearylfumarate; croscarmellose sodium; lactose monohydrate

Spôsob podávania:

Oral

Počet v balení:

28, 30

Typ predpisu:

(S4) Prescription Only Medicine

Terapeutické indikácie:

? Treatment of hypertension. Data are currently not available to support the use of Ramipril in renovascular hypertension. ,? Post MI heart failure ,? Prevention of progressive renal failure in patients with persistent proteinuria in excess of 1 g/day. ,? For reducing the risk of myocardial infarction, stroke, cardiovascular death or the need for revascularisation procedures in patients 55 years of age or more who have clinical evidence of coronary artery disease, stroke, or peripheral vascular disease. ,? For reducing the risk of myocardial infarction, stroke, cardiovascular death or revascularization procedures in diabetic patients 55 years or more with one or more of the following risk factors: systolic blood pressure >160mmHg or diastolic blood pressure >90mmHg (or on antihypertensive treatment); total cholesterol >5.2mmol/L; HDL cholesterol <0.9mmol/L; current smoker; known microalbuminuria; any evidence of previous vascular disease.

Prehľad produktov:

Visual Identification: Light yellow to yellow coloured flat faced bevel edged, round uncoated tablet debossed with 'H' & '18' separated by score line on one side and plain on other side; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Stav Autorizácia:

Registered

Dátum Autorizácia:

2011-10-06